Bone Marrow TransplantationTransplantation, HomologousBone MarrowBone Marrow CellsTransplantation, AutologousLiver TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationKidney TransplantationGraft SurvivalTransplantation ChimeraTissue DonorsAnemia, AplasticLeukemiaHeart TransplantationHistocompatibility TestingBusulfanTransplantation, IsogeneicHistocompatibilityLung TransplantationBone Marrow PurgingStem Cell TransplantationBone and BonesGraft RejectionHematopoietic Stem CellsCyclophosphamideTransplantation ImmunologyImmunosuppressive AgentsRecurrenceTreatment OutcomeOrgan TransplantationBone Marrow DiseasesCombined Modality TherapyHematopoiesisTime FactorsHematologic NeoplasmsMice, Inbred C57BLImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraLeukemia, Myeloid, AcuteRemission InductionHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesPancreas TransplantationBone Marrow ExaminationGraft vs Host ReactionIslets of Langerhans TransplantationAcute DiseaseCell TransplantationSurvival AnalysisLeukemia, MyeloidLymphocyte DepletionTransplantationLymphoma, Non-HodgkinLeukocyte TransfusionHLA AntigensCyclosporineBone Marrow NeoplasmsT-LymphocytesSevere Combined ImmunodeficiencyCord Blood Stem Cell TransplantationMyelodysplastic SyndromesChimeraColony-Forming Units AssayActuarial AnalysisFollow-Up StudiesSurvival RateLymphocyte TransfusionHematologic DiseasesLiving DonorsAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationTransplantation ToleranceCytomegalovirus InfectionsGraft vs Tumor EffectCarmustineNuclear FamilyGraft vs Leukemia EffectDisease-Free SurvivalCell DifferentiationSkin TransplantationMelphalanCytarabinePostoperative ComplicationsPancytopeniaGranulocyte Colony-Stimulating FactorLeukocyte CountTransplantation, HeterotopicAntilymphocyte SerumBone RemodelingMultiple MyelomaSpleenMice, Inbred BALB CEtoposideLymphomaPrognosis